All members of ATA Committees & Task Forces must review the ATA’s Financial Disclosure and Duality of Interest Policy and complete the form at the end of this page confirming acknowledgement.
Statement of Policy – ATA Policies and Procedures (excerpted for ATA Committee members)
-
No Committee member shall use his or her position, or the knowledge gained there from, in such a manner that a conflict between the interest of the ATA or any of its affiliates and his or her personal interests arises.
-
Each Committee member has a duty to place the interest of the ATA foremost in any dealings with the organization and has a continuing responsibility to comply with the requirements of this policy.
-
Committee members may not obtain for themselves, their relatives, or their friends a material interest of any kind from their association with the ATA.
-
If a Committee member has an interest in a proposed transaction with the ATA in the form of a significant personal financial interest in the transaction or in any organization involved in the transaction or holds a position as trustee, director, or officer in any such organization, he or she must make full disclosure of such interest before any discussion or negotiation of such transaction.
Any Committee member who is aware of a potential conflict of interest with respect to any matter coming before the committee shall not be present for any discussion of or vote in connection with the matter.
The ATA President, Secretary/Chief Operating Officer, and Treasurer take the following steps during their terms of office to avoid actual or perceived conflicts of commitment and ensure their unimpeded active involvement in issues of importance to the Association:
1. Resign from consultancies with all pharmaceutical, laboratory diagnostic, and any other firms in the field of endocrinology and metabolism, or that otherwise interface with the Association;
2. Divest themselves of equities in such firms;
3. Accept no direct honoraria for lectures or other services from such firms; and
4. Simultaneously hold no other major leadership positions in other professional societies
Financial Disclosure & Duality of Interest Standards
Committee members of the ATA shall submit annual Conflict-of-interest Statements and, if not previously disclosed, shall make disclosure before any relevant Board of Directors or committee action.
Conflict-of-interest Statements shall be reviewed by the Secretary/Chief Operating Officer, who will attempt to resolve any actual or potential conflict(s) and, in the absence of resolution, refer the matter to the ATA Board of Directors.
The statement will describe all of your relationships with companies that make products relevant to the decisions and discussions you engage in as an officer with the American Thyroid Association, specifying the type of relationship (e.g., consulting, paid speaking, grant support, equity, and patents) that you have with each company.
When uncertainty exists about the existence of conflict or about the perception of conflict of interest, the Officer or Director should bring the matter to the attention of the Board of Directors (or to a committee of senior members appointed annually for this purpose, by the President.)
American Thyroid Association Financial Disclosure Form
Each ATA leader is required to complete this form.
The interest extends to those areas relevant to the committee decisions that, broadly viewed, could be construed as constituting a conflict of interest or the appearance thereof. The information will be used only in paraphrase to write disclosure statements.
PLEASE REVIEW CAREFULLY and COMPLETE EACH SECTION
* Financial Relationships are those relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g. stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected.
** A Commercial Interest is any proprietary entity producing health care goods and services with the exception of non-profit or government organizations and non-health care related companies.
*** Relevant Financial Relationships. The ACCME defines “’relevant’ financial relationships” as financial relationships in any amount occurring within the past 12 months that create a conflict of interest. This includes any relationship that could be potentially perceived as a conflict of interest.
